Takaisin Tulosta

Siedätyshoidon immunologiset mekanismit

Lisätietoa aiheesta
Tuomas Virtanen
14.8.2019

Kirjallisuutta

  1. Noval Rivas M, Chatila TA. Regulatory T cells in allergic diseases. J Allergy Clin Immunol 2016;138:639-652 «PMID: 27596705»PubMed
  2. Schulten V, Tripple V, Seumois G ym. Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells. J Allergy Clin Immunol 2018;141:775-777.e6 «PMID: 28506846»PubMed
  3. Bacher P, Scheffold A. Antigen-specific regulatory T-cell responses against aeroantigens and their role in allergy. Mucosal Immunol 2018;11:1537-1550 «PMID: 29858582»PubMed
  4. Stanic B, van de Veen W, Wirz OF ym. IL-10-overexpressing B cells regulate innate and adaptive immune responses. J Allergy Clin Immunol 2015;135:771-80.e8 «PMID: 25240783»PubMed
  5. Boonpiyathad T, Meyer N, Moniuszko M ym. High-dose bee venom exposure induces similar tolerogenic B-cell responses in allergic patients and healthy beekeepers. Allergy 2017;72:407-415 «PMID: 27341567»PubMed
  6. Wambre E, DeLong JH, James EA ym. Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner. J Allergy Clin Immunol 2014;133:872-9.e7 «PMID: 24373351»PubMed
  7. Ryan JF, Hovde R, Glanville J ym. Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets. Proc Natl Acad Sci U S A 2016;113:E1286-95 «PMID: 26811452»PubMed
  8. Wambre E, Bajzik V, DeLong JH ym. A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders. Sci Transl Med 2017;9: «PMID: 28768806»PubMed
  9. Yao Y, Chen CL, Wang N ym. Correlation of allergen-specific T follicular helper cell counts with specific IgE levels and efficacy of allergen immunotherapy. J Allergy Clin Immunol 2018;142:321-4
  10. Guerra F, Carracedo J, Solana-Lara R ym. TH2 lymphocytes from atopic patients treated with immunotherapy undergo rapid apoptosis after culture with specific allergens. J Allergy Clin Immunol 2001;107:647-53 «PMID: 11295653»PubMed
  11. Möbs C, Ipsen H, Mayer L ym. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies. J Allergy Clin Immunol 2012;130:1108-1116.e6 «PMID: 23021882»PubMed
  12. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 2004;113:395-400 «PMID: 14758340»PubMed
  13. Angelini F, Pacciani V, Corrente S ym. Dendritic cells modification during sublingual immunotherapy in children with allergic symptoms to house dust mites. World J Pediatr 2011;7:24-30 «PMID: 21191773»PubMed
  14. Zimmer A, Bouley J, Le Mignon M ym. A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy. J Allergy Clin Immunol 2012;129:1020-30 «PMID: 22464673»PubMed
  15. Allam JP, Würtzen PA, Reinartz M ym. Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties. J Allergy Clin Immunol 2010;126:638-45.e1 «PMID: 20584546»PubMed
  16. Lao-Araya M, Steveling E, Scadding GW ym. Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy. J Allergy Clin Immunol 2014;134:1193-5.e4 «PMID: 25212194»PubMed
  17. Novak N, Mete N, Bussmann C ym. Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. J Allergy Clin Immunol 2012;130:1153-1158.e2 «PMID: 22698521»PubMed
  18. Nouri-Aria KT, Pilette C, Jacobson MR ym. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. J Allergy Clin Immunol 2005;116:73-9 «PMID: 15990777»PubMed
  19. Wilson DR, Irani AM, Walker SM ym. Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy 2001;31:1705-13 «PMID: 11696046»PubMed
  20. Wilson DR, Nouri-Aria KT, Walker SM ym. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol 2001;107:971-6 «PMID: 11398073»PubMed
  21. Lichtenstein LM, Ishizaka K, Norman PS ym. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy. J Clin Invest 1973;52:472-82 «PMID: 4119162»PubMed
  22. Aalberse RC, Schuurman J. IgG4 breaking the rules. Immunology 2002;105:9-19 «PMID: 11849310»PubMed
  23. Wachholz PA, Durham SR. Mechanisms of immunotherapy: IgG revisited. Curr Opin Allergy Clin Immunol 2004;4:313-8 «PMID: 15238798»PubMed
  24. van Neerven RJ, Wikborg T, Lund G ym. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol 1999;163:2944-52 «PMID: 10453043»PubMed
  25. Jutel M, Jaeger L, Suck R ym. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005;116:608-13 «PMID: 16159631»PubMed
  26. Reisinger J, Horak F, Pauli G ym. Allergen-specific nasal IgG antibodies induced by vaccination with genetically modified allergens are associated with reduced nasal allergen sensitivity. J Allergy Clin Immunol 2005;116:347-54 «PMID: 16083789»PubMed